BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

ViaCyte, Inc. (Formerly Known as Novocell, Inc.) 

3550 General Atomics Court
Building 2, Room 503
San Diego  California  92121  U.S.A.
Phone: 858-455-3708 Fax: 858-455-3962


SEARCH JOBS








 Company News
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Appoints Mark Foletta, Former CFO Of Amylin Pharmaceuticals, Inc. (AMLN), To Its Board Of Directors 12/19/2013 8:01:31 AM    More...
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) To Present At The 25th Piper Jaffray Healthcare Conference 12/3/2013 8:03:31 AM    More...
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Granted Over 20 Patents in 2013 Further Establishing the Company as a Leader in the Field of Regenerative Medicine 10/30/2013 8:56:18 AM    More...
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) to Present at the JDRF 8th Annual T1D Global Path to a Cure Symposium 10/16/2013 10:32:15 AM    More...
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) to Present Update on VC-01™ Combination Product Development at 2013 Stem Cell Meeting on the Mesa 10/11/2013 6:09:51 AM    More...
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Nabs $10.6 Million in a Private Financing 7/10/2013 6:54:54 AM    More...
ViaCyte, Inc. (Formerly Known as Novocell, Inc.)'s Role as a Leading Cell Therapy Company Bolstered With the Issuance of 20 Patents in 2012 1/31/2013 9:01:40 AM    More...
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Appoints Steve Altman to Its Board of Directors 10/29/2012 10:29:25 AM    More...
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Gets $10.1 Million State Stem Cell Agency Grant for Artificial Pancreas 10/26/2012 7:16:54 AM    More...
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Appoints Dr. Paul Laikind Chief Executive Officer 6/15/2012 7:36:44 AM    More...
1234

//-->